CN115999462A - A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application - Google Patents
A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application Download PDFInfo
- Publication number
- CN115999462A CN115999462A CN202210636699.5A CN202210636699A CN115999462A CN 115999462 A CN115999462 A CN 115999462A CN 202210636699 A CN202210636699 A CN 202210636699A CN 115999462 A CN115999462 A CN 115999462A
- Authority
- CN
- China
- Prior art keywords
- mat
- pro
- water
- nanocapsules
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002088 nanocapsule Substances 0.000 title claims abstract description 117
- 239000002519 antifouling agent Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229920001661 Chitosan Polymers 0.000 claims abstract description 128
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 claims abstract description 60
- 229930182820 D-proline Natural products 0.000 claims abstract description 60
- 239000003094 microcapsule Substances 0.000 claims abstract description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000000243 solution Substances 0.000 claims abstract description 38
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims abstract description 15
- 238000000593 microemulsion method Methods 0.000 claims abstract description 13
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims abstract description 12
- 238000000502 dialysis Methods 0.000 claims abstract description 12
- 229930014456 matrine Natural products 0.000 claims abstract description 12
- 230000004044 response Effects 0.000 claims abstract description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 11
- 239000000787 lecithin Substances 0.000 claims abstract description 11
- 229940067606 lecithin Drugs 0.000 claims abstract description 11
- 235000010445 lecithin Nutrition 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 10
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 239000005457 ice water Substances 0.000 claims abstract description 5
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000004108 freeze drying Methods 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 23
- 229960000583 acetic acid Drugs 0.000 claims description 11
- 239000008055 phosphate buffer solution Substances 0.000 claims description 5
- 238000005202 decontamination Methods 0.000 claims description 2
- 230000003588 decontaminative effect Effects 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 239000004005 microsphere Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000009827 uniform distribution Methods 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 68
- 230000003373 anti-fouling effect Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 9
- 238000011160 research Methods 0.000 abstract description 5
- 239000002114 nanocomposite Substances 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 description 35
- 241000894006 Bacteria Species 0.000 description 27
- 241000588724 Escherichia coli Species 0.000 description 25
- 239000012071 phase Substances 0.000 description 23
- 230000001580 bacterial effect Effects 0.000 description 20
- 239000003921 oil Substances 0.000 description 19
- 239000002609 medium Substances 0.000 description 17
- 239000002953 phosphate buffered saline Substances 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 15
- 239000000725 suspension Substances 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000002378 acidificating effect Effects 0.000 description 9
- 230000003214 anti-biofilm Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 241000894007 species Species 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- KNVAYBMMCPLDOZ-UHFFFAOYSA-N propan-2-yl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OC(C)C KNVAYBMMCPLDOZ-UHFFFAOYSA-N 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000007127 saponification reaction Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000004627 transmission electron microscopy Methods 0.000 description 5
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 4
- 230000037358 bacterial metabolism Effects 0.000 description 4
- 230000032770 biofilm formation Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000005595 deprotonation Effects 0.000 description 4
- 238000010537 deprotonation reaction Methods 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000003100 immobilizing effect Effects 0.000 description 4
- 150000003951 lactams Chemical group 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000005588 protonation Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 3
- 238000003917 TEM image Methods 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000012703 microemulsion polymerization Methods 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 231100000956 nontoxicity Toxicity 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- FBVVGPMIPAZFAW-DGPROHSZSA-N (2R)-pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1.OC(=O)[C@H]1CCCN1 FBVVGPMIPAZFAW-DGPROHSZSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 150000008574 D-amino acids Chemical class 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000009881 electrostatic interaction Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 241000206761 Bacillariophyta Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000960592 Pseudomonas aeruginosa group Species 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000002579 anti-swelling effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- YEPGIYSLLAGBSS-UHFFFAOYSA-M chloro-[3-[(4-iodophenyl)carbamoylamino]-2-methoxypropyl]mercury Chemical compound Cl[Hg]CC(OC)CNC(=O)NC1=CC=C(I)C=C1 YEPGIYSLLAGBSS-UHFFFAOYSA-M 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000011224 negative regulation of urine volume Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种环境友好的pH响应型Mat@CS-Pro抑菌协同抗生物膜防污胶囊及其制备方法,属于海洋抑菌防污及纳米复合材料技术领域。The invention relates to an environmentally friendly pH-responsive Mat@CS-Pro antibacterial synergistic anti-biofilm antifouling capsule and a preparation method thereof, belonging to the technical field of marine antibacterial antifouling and nanocomposite materials.
背景技术Background technique
海洋生物污损是一个世界性的问题,对我们的日常生活产生了巨大的影响,尤其是航运带来的经济损失和工程设备的安全风险。当材料浸于海水中后海洋中污损生物会附着于舰船底部,增加航行阻力、降低船速、多耗燃料,严重影响持续性使用,此外其还会加速金属腐蚀,缩短仪器设备的使用寿命甚至造成生物入侵等严重的生态破坏,对人类海洋方面的发展造成巨大影响。由于微生物膜的形成是后续大型污损生物附着固定的基本条件,因此将海洋防污转化成生物污损前期过程中的对抗菌、抗生物膜形成过程的研究是一种行之有效的防治生物污损的思路与方法。此外,由于细菌代谢产生的醋酸和乳酸等分泌物可使微环境的pH值降低至酸性,因此近年来基于pH响应型的防污涂料受到越来越多的关注并得到迅速发展。除此之外,材料表面形成的生物膜也是一个需要考虑的重要问题。Marine biofouling is a worldwide problem, which has a huge impact on our daily life, especially the economic loss caused by shipping and the safety risk of engineering equipment. When the material is immersed in seawater, fouling organisms in the ocean will adhere to the bottom of the ship, increasing navigation resistance, reducing ship speed, and consuming more fuel, seriously affecting continuous use. In addition, it will also accelerate metal corrosion and shorten the use of equipment. Lifespan even causes serious ecological damage such as biological invasion, which has a huge impact on the development of human oceans. Since the formation of microbial film is the basic condition for subsequent large-scale fouling organisms to adhere and fix, the research on the formation process of antibacterial and anti-biofouling in the process of converting marine antifouling into biofouling is an effective way to prevent and control organisms. Ideas and methods of defacement. In addition, because secretions such as acetic acid and lactic acid produced by bacterial metabolism can lower the pH value of the microenvironment to acidity, pH-responsive antifouling coatings have received more and more attention and developed rapidly in recent years. In addition, the biofilm formed on the surface of the material is also an important issue to be considered.
污损过程初期阶段为细菌和硅藻分泌粘液在海中洁净物体表面形成微生物粘膜,发展阶段为大型污损生物的幼体开始附着,种类和个体数不断增多,群落体积和质量不断增大,演替现象明显,一些个体密度大,生长迅速的种类成为群落的主导种;稳定阶段为生长期长、个体大的种类充分生长,排挤或覆盖了一些附着的中、小型种类,复杂和质量较大的群落种形成。因此生物膜形成为后续大型污损生物附着创造了条件,进而导致生物污损的形成。所以控制微生物膜的形成也是生物污损的一项必要条件。然而,当前国内外对于防污剂的研究重点主要集中在抗菌性能提升,而在提升杀菌作用的基础上,引入抑制生物膜能力的相关研究却鲜有报道。In the initial stage of the fouling process, bacteria and diatoms secrete mucus to form microbial mucous membranes on the surface of clean objects in the sea. In the developmental stage, the larvae of large fouling organisms begin to attach. The species and number of individuals continue to increase, and the volume and quality of the community continue to increase. The phenomenon is obvious. Some species with high individual density and rapid growth become the dominant species in the community; in the stable stage, species with long growth period and large individuals grow fully, crowding out or covering some attached medium and small species, complex and large species Community species formation. Therefore, the formation of biofilm creates conditions for subsequent large-scale fouling organisms to attach, which in turn leads to the formation of biofouling. Therefore, controlling the formation of microbial film is also a necessary condition for biofouling. However, the current research on antifouling agents at home and abroad mainly focuses on the improvement of antibacterial performance, but there are few reports on the introduction of anti-biofilm ability on the basis of improving the bactericidal effect.
发明内容Contents of the invention
为了解决以上问题,本发明技术方案提出一种环境友好的pH响应型Mat@CS-Pro纳米胶囊防污剂及其制备方法,以天然有机苦参碱(matrine,Mat)作为芯材,以天然高分子壳聚糖(chitosan,CS)作为壁材,通过微乳液聚合法制备CS包封Mat的微胶囊,并通过冷浴搅拌的方法将D-脯氨酸(D-Proline)固定到胶囊上,最终制备出高性能的智能pH响应抗菌/生物膜防污剂。绿色无毒的Mat@CS胶囊将提高抗菌剂Mat的稳定性,降低其碱性环境下变性的可能,使得微胶囊的杀菌效率实现最大化,通过CS的pH响应作用,使Mat及D-Proline的释放更加智能、可持续化。首先以CS为水相,以Mat为油相,利用微乳液法制备O/W结构微胶囊。通过透射电子显微镜(TEM)分析不同pH下Mat@CS及Mat@CS-Pro微胶囊的形态和尺寸。通过傅里叶红外光谱(FTIR)分析微胶囊的特征官能团并判断微胶囊成分。采用平板菌落计数法及荧光活/死菌检测分析负载D-Proline前后的微胶囊的抑菌性能及抑制生物膜形成能力,并通过平板菌落计数法观察不同pH下的微胶囊杀菌情况,对负载D-Proline的微胶囊进行不同pH下释药率表征,综合分析微胶囊的pH响应长效杀菌机理。In order to solve the above problems, the technical solution of the present invention proposes an environmentally friendly pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method, using natural organic matrine (matrine, Mat) as the core material, and using natural Polymer chitosan (chitosan, CS) was used as the wall material, and the microcapsules of CS encapsulated Mat were prepared by microemulsion polymerization, and D-Proline (D-Proline) was fixed on the capsules by stirring in a cold bath , and finally prepared a high-performance smart pH-responsive antibacterial/biofilm antifouling agent. The green and non-toxic Mat@CS capsule will improve the stability of the antimicrobial agent Mat, reduce the possibility of denaturation in an alkaline environment, and maximize the bactericidal efficiency of the microcapsules. Through the pH response of CS, Mat and D-Proline The release is more intelligent and sustainable. First, using CS as the water phase and Mat as the oil phase, O/W microcapsules were prepared by microemulsion method. The morphology and size of Mat@CS and Mat@CS-Pro microcapsules at different pH were analyzed by transmission electron microscopy (TEM). The characteristic functional groups of the microcapsules were analyzed by Fourier transform infrared spectroscopy (FTIR) and the components of the microcapsules were judged. The plate colony counting method and fluorescent live/dead bacteria detection were used to analyze the antibacterial performance and biofilm formation ability of the microcapsules before and after loading D-Proline, and the microcapsule sterilization at different pH was observed by the plate colony counting method. The microcapsules of D-Proline were characterized by drug release rate at different pH, and the pH-responsive long-term bactericidal mechanism of the microcapsules was comprehensively analyzed.
本发明通过微乳液聚合法制备出具有pH响应性质的杀菌微胶囊,同时负载D-Proline成功合成具有pH响应的抗菌和抗生物膜特性的防污胶囊。该Mat@CS-Pro微胶囊具有优异的抗菌、抗生物膜和pH响应性能,其具备可稳定存在、智能控制释放、延长抗菌剂的使用寿命及对环境友好等功能,具有广泛的应用前景。The invention prepares bactericidal microcapsules with pH response properties through microemulsion polymerization, and at the same time loads D-Proline to successfully synthesize antifouling capsules with pH response antibacterial and anti-biofilm properties. The Mat@CS-Pro microcapsule has excellent antibacterial, anti-biofilm and pH responsive properties, and has the functions of stable existence, intelligent control release, prolonging the service life of antibacterial agents and being environmentally friendly, and has a wide range of application prospects.
本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:
根据本发明的第一方面,提供一种环境友好的pH响应型Mat@CS-Pro纳米胶囊防污剂的制备方法,所述制备方法包括:According to the first aspect of the present invention, there is provided a method for preparing an environmentally friendly pH-responsive Mat@CS-Pro nanocapsule antifouling agent, the preparation method comprising:
(1)将天然有机苦参碱(matrine,Mat)溶于含卵磷脂的无水乙醇中,制备油相;(1) dissolving natural organic matrine (matrine, Mat) in absolute ethanol containing lecithin to prepare an oil phase;
(2)将天然高分子壳聚糖(chitosan,CS)溶于无水乙酸制备水相;(2) dissolving natural polymer chitosan (chitosan, CS) in anhydrous acetic acid to prepare an aqueous phase;
(3)通过微乳液法制备Mat@CS油/水(O/W)微胶囊,水相油相混溶后水相开始包覆油相,形成外壳为CS、核心为Mat的Mat@CS油/水(O/W)微胶囊;(3) Mat@CS oil/water (O/W) microcapsules were prepared by the microemulsion method. After the water phase and oil phase were miscible, the water phase began to coat the oil phase, forming a Mat@CS oil with CS as the shell and Mat as the core. /water (O/W) microcapsules;
(4)取制备好的所述Mat@CS油/水(O/W)微胶囊与D-Proline配制成水溶液,在冰水浴中进行搅拌,在去离子水溶液中经过透析袋透析过滤,然后冻干保存,由此得到所述pH响应型Mat@CS-Pro纳米胶囊防污剂。(4) Take the prepared Mat@CS oil/water (O/W) microcapsules and D-Proline to prepare an aqueous solution, stir in an ice-water bath, dialysis filter through a dialysis bag in a deionized aqueous solution, and then freeze Dry storage, thus obtaining the pH-responsive Mat@CS-Pro nanocapsule antifouling agent.
进一步地,步骤(1)所述的Mat量为10~40mg,所述含卵磷脂的无水乙醇浓度为20-40mg/mL,优选为30mg/mL,体积为200~500μL。Further, the amount of Mat in step (1) is 10-40 mg, the lecithin-containing absolute ethanol concentration is 20-40 mg/mL, preferably 30 mg/mL, and the volume is 200-500 μL.
进一步地,步骤(2)所述的CS量为5-15mg,优选为10mg,乙酸水溶液(1%,v/v),体积为10-30mL,优选为20mL。Further, the amount of CS in step (2) is 5-15 mg, preferably 10 mg, and the volume of acetic acid aqueous solution (1%, v/v) is 10-30 mL, preferably 20 mL.
进一步地,步骤(3)所述的微乳液法为:分别取所述水相与油相,将所述油相缓缓加入到水相制备成分布均匀的微球,以100~400rpm的转速进行搅拌,搅拌时间为1~3h以上,在PBS磷酸盐缓冲溶液经过透析袋透析过滤,然后冻干保存,得到所述Mat@CS油/水(O/W)微胶囊。Further, the microemulsion method described in step (3) is: take the water phase and the oil phase respectively, slowly add the oil phase to the water phase to prepare uniformly distributed microspheres, and use the speed of 100-400rpm Stirring, the stirring time is more than 1-3h, dialysis filtration in PBS phosphate buffer solution through a dialysis bag, and then freeze-dried and stored to obtain the Mat@CS oil/water (O/W) microcapsules.
进一步地,所述PBS磷酸盐缓冲溶液pH为7.4。Further, the pH of the PBS phosphate buffer solution is 7.4.
进一步地,所述水相为冰醋酸、CS、去离子水,所述油相为卵磷脂、无水乙醇、Mat。Further, the water phase is glacial acetic acid, CS, and deionized water, and the oil phase is lecithin, absolute ethanol, and Mat.
进一步地,步骤(4)所述的Mat@CS胶囊质量为20~40mg,D-Proline质量为10~20mg,Mat@CS油/水(O/W)微胶囊与D-Proline的质量比为1-5:1,优选为2:1;所加的去离子水溶液体积为10-30mL,优选为20mL,在冰水浴中进行搅拌,搅拌转速为100~400rpm,搅拌时间为40~50h,优选为48h。Further, the mass of Mat@CS capsules described in step (4) is 20-40 mg, the mass of D-Proline is 10-20 mg, and the mass ratio of Mat@CS oil/water (O/W) microcapsules to D-Proline is 1-5:1, preferably 2:1; the volume of the added deionized water solution is 10-30mL, preferably 20mL, stirred in an ice-water bath, the stirring speed is 100-400rpm, and the stirring time is 40-50h, preferably for 48h.
根据本发明的第二方面,提供一种环境友好的pH响应型Mat@CS-Pro纳米胶囊防污剂,所述pH响应型Mat@CS-Pro纳米胶囊防污剂采用根据以上任一方面的制备方法制备获得。According to the second aspect of the present invention, there is provided an environmentally friendly pH-responsive Mat@CS-Pro nanocapsule antifouling agent, the pH-responsive Mat@CS-Pro nanocapsule antifouling agent adopts any of the above The preparation method is prepared.
进一步地,所述pH响应型Mat@CS-Pro纳米胶囊大致呈球形,粒径在200~500nm之间。该制备的胶囊具有智能pH响应性能,在海洋(碱性)条件下,CS能够充分维持内部Mat的抑菌活性,当微生物大量繁殖引起周围酸化后,微胶囊结构发生变化使Mat及D-Proline释放,实现智能响应防污的目的。Further, the pH-responsive Mat@CS-Pro nanocapsules are roughly spherical, and the particle diameter is between 200-500nm. The prepared capsules have intelligent pH response properties. Under marine (alkaline) conditions, CS can fully maintain the antibacterial activity of the internal Mat. release, to achieve the purpose of intelligent response antifouling.
根据本发明的第三方面,提供一种环境友好的pH响应型Mat@CS-Pro纳米胶囊防污剂在海洋环境去污中的应用。According to the third aspect of the present invention, an application of an environmentally friendly pH-responsive Mat@CS-Pro nanocapsule antifouling agent in marine environment decontamination is provided.
进一步地,所述pH响应型Mat@CS-Pro纳米胶囊防污剂所应用于的海洋环境pH值范围为8.0~8.3。Further, the pH-value range of the marine environment to which the pH-responsive Mat@CS-Pro nanocapsule antifouling agent is applied is 8.0-8.3.
本发明的有益效果:Beneficial effects of the present invention:
本发明通过微乳液法制备O/W结构Mat@CS-Pro纳米微胶囊使Mat在海水中稳定存在,减小Mat与外界环境中O2发生氧化反应及发生皂化反应的可能。Mat@CS-Pro纳米微胶囊对S.aureus、P.aeruginosa和大肠杆菌(E.coli)均表现出出色的抑菌性能,胶囊展示出其具有智能pH响应控释抑菌和抑制生物膜形成作用。在海洋环境中,细菌代谢产生的分泌物会导致局部pH值降低,由于Mat@CS-Pro胶囊外壳CS中氨基的质子化过程,CS分子间发生静电排斥作用使胶囊膨胀释放Mat以杀死细菌,同时D-proline由于小于等电点而带正电,与CS带同种电荷,因而两者产生静电互斥作用,促进了D-Proline的释放进而抑制生物膜的形成,表现出胶囊杀菌协同抗生物膜的双重功效。而pH较高时氨基去质子化,胶囊缩小Mat不释放,Mat不与碱性环境直接接触,减小了Mat的内酰胺结构直接暴露于碱性环境中发生皂化反应而导致变性的可能,使得Mat长期稳定存在。同时D-Proline因在碱性环境中的所带电荷与CS一样均为负电荷,因此在碱性环境中D-Proline亦能释放抑制生物膜的形成进行防污。The present invention prepares O/W structure Mat@CS-Pro nano microcapsules by microemulsion method so that Mat can exist stably in seawater, reducing the possibility of oxidation reaction and saponification reaction between Mat and O2 in the external environment. Mat@CS-Pro nanocapsules exhibited excellent antibacterial properties against S.aureus, P.aeruginosa and Escherichia coli (E.coli), and the capsules exhibited intelligent pH-responsive controlled-release bacteriostasis and inhibition of biofilm formation effect. In the marine environment, the secretions produced by bacterial metabolism will lead to a decrease in the local pH value. Due to the protonation process of the amino group in the CS of the Mat@CS-Pro capsule shell, electrostatic repulsion occurs between the CS molecules and the capsule expands to release Mat to kill the bacteria. , at the same time, D-proline is positively charged because it is less than the isoelectric point, and has the same charge as CS, so the two produce electrostatic mutual repulsion, which promotes the release of D-Proline and inhibits the formation of biofilm, showing the synergy of capsule sterilization Dual efficacy against biofilms. When the pH is high, the amino group is deprotonated, the capsule shrinks and Mat does not release, and Mat does not directly contact with the alkaline environment, which reduces the possibility that the lactam structure of Mat is directly exposed to the saponification reaction in the alkaline environment and causes denaturation. Mat exists stably for a long time. At the same time, because D-Proline is negatively charged like CS in alkaline environment, D-Proline can also release and inhibit the formation of biofilm in alkaline environment for antifouling.
本发明将D-Proline与Mat@CS按质量比为1-5:1(优选为2:1)配置成水溶液,在冰浴中搅拌使D-Proline固定到Mat@CS胶囊上,使Mat@CS抗菌防污的同时增加了D-氨基酸抗生物膜防污功能,D-Proline通过静电作用吸附固定到Mat@CS表面,在酸性条件下胶囊膨胀时同时释放Mat@CS和D-Proline,实现了胶囊抗菌、抗生物膜双重功能,表现出很好的防污性能。In the present invention, D-Proline and Mat@CS are configured into an aqueous solution at a mass ratio of 1-5:1 (preferably 2:1), and stirred in an ice bath to fix D-Proline on the Mat@CS capsule, so that Mat@ CS is antibacterial and antifouling while adding D-amino acid anti-biofilm antifouling function. D-Proline is adsorbed and fixed to the surface of Mat@CS through electrostatic interaction. When the capsule expands under acidic conditions, Mat@CS and D-Proline are released simultaneously to realize It has the dual functions of capsule antibacterial and anti-biofilm, and shows good antifouling performance.
附图说明Description of drawings
图1是不同pH值下Mat@CS(a、b部分)和Mat@CS-Pro(c、d部分)纳米胶囊的TEM图像。Figure 1 is the TEM images of Mat@CS (part a, b) and Mat@CS-Pro (part c, d) nanocapsules at different pH values.
图2是根据本发明实施例的FTIR光谱示意图,其中,图2中a部分是Mat@CS纳米胶囊、Mat和CS的FTIR光谱,b部分是Mat@CS-Pro纳米胶囊、Mat@CS纳米胶囊和D-Proline的FTIR光谱。Figure 2 is a schematic diagram of the FTIR spectrum according to an embodiment of the present invention, wherein, in Figure 2, part a is the FTIR spectrum of Mat@CS nanocapsules, Mat and CS, and part b is Mat@CS-Pro nanocapsules, Mat@CS nanocapsules and FTIR spectra of D-Proline.
图3是Mat、CS和Mat@CS纳米胶囊在Luria-Bertani培养液(LB)及2216E培养基中作用18h后E.coli、S.aureus、P.aeruginosa的数量(a部分),以及各计数结果对应的抑菌效果(b部分)。Figure 3 is the number of E.coli, S.aureus, P.aeruginosa (part a) and the counts of Mat, CS and Mat@CS nanocapsules in Luria-Bertani culture medium (LB) and 2216E medium for 18 hours The results correspond to the antimicrobial effect (part b).
图4是Mat@CS纳米胶囊、D-Proline和Mat@CS-Pro纳米胶囊分别作用于LB培养基18h后E.coli、S.aureus、P.aeruginosa的数量(a部分),以及各菌落计数结果对应的抑菌效果图(b部分)。Figure 4 shows the number of E.coli, S.aureus, and P.aeruginosa after Mat@CS nanocapsules, D-Proline and Mat@CS-Pro nanocapsules were applied to LB medium for 18 hours (part a), and the colony counts The antibacterial effect diagram corresponding to the results (part b).
图5是未经处理的E.coli(a部分)和Mat@CS-Pro纳米胶囊处理的E.coli(a1部分)的SEM图像;未处理的S.aureus(b部分)和Mat@CS-Pro纳米胶囊处理的S.aureus(b1部分);未经处理的P.aeruginosa(c部分)和Mat@CS-Pro纳米胶囊处理的P.aeruginosa(c1部分)。Figure 5 is the SEM image of untreated E.coli (part a) and E.coli treated with Mat@CS-Pro nanocapsules (part a 1 ); untreated S.aureus (part b) and Mat@CS-Pro - S. aureus treated with Pro nanocapsules (part b 1 ); untreated P. aeruginosa (part c) and P. aeruginosa treated with Mat@CS-Pro nanocapsules (part c 1 ).
图6是E.coli(a-c部分)、S.aureus(a1-c1部分)和P.aeruginosa(a2-c2部分)在添加与不添加Mat@CS和Mat@CS-Pro纳米胶囊的培养基中培养后所对应试片上生物膜的SEM图像。Figure 6 is E.coli (part ac), S.aureus (part a 1 -c 1 ) and P.aeruginosa (part a 2 -c 2 ) with and without Mat@CS and Mat@CS-Pro nanocapsules The SEM image of the biofilm on the corresponding test piece after culturing in the culture medium of .
图7是图6中E.coli(a-c部分)、S.aureus(a1-c1部分)和P.aeruginosa(a2-c2部分)在Mat@CS和Mat@CS-Pro纳米胶囊条件下培养3天后形成的生物膜的厚度图。Figure 7 shows E.coli (part ac), S.aureus (part a 1 -c 1 ) and P.aeruginosa (part a 2 -c 2 ) in Mat@CS and Mat@CS-Pro nanocapsule conditions in Figure 6 Thickness graph of the biofilm formed after 3 days of incubation.
图8是在pH 5(a部分)和pH 8(b部分)条件下Mat@CS纳米胶囊的TEM图像;Mat@CS-Pro纳米胶囊在pH 5(c部分)和pH 8(d部分)条件下的TEM图像。Figure 8 is the TEM image of Mat@CS nanocapsules at pH 5 (part a) and pH 8 (part b); Mat@CS-Pro nanocapsules at pH 5 (part c) and pH 8 (part d) TEM image below.
图9是Mat在PBS溶液中的标准曲线(a部分);从Mat@CS-Pro纳米胶囊中释放的Mat在不同pH的PBS溶液中10h的浓度(b部分);Mat@CS-Pro纳米胶囊在不同pH值PBS溶液中处理后的直径(c部分);在含有Mat@CS-Pro纳米胶囊的不同pH的LB和PBS溶液(体积比1∶1)中培养4h(d部分)后,三种不同类型的细菌菌株的光密度(O.D.)值。Figure 9 is the standard curve of Mat in PBS solution (part a); the concentration of Mat released from Mat@CS-Pro nanocapsules in PBS solutions of different pH for 10h (part b); Mat@CS-Pro nanocapsules Diameter after treatment in PBS solutions with different pH values (part c); after incubation for 4 h in LB and PBS solutions (volume ratio 1:1) containing Mat@CS-Pro nanocapsules (part d), three Optical density (O.D.) values of different types of bacterial strains.
图10是Mat@CS-Pro在pH 5、6、7和8培养基中对抗E.coli(a-d部分)、S.aureus(a1-d1部分)和P.aeruginosa(a2-d2部分)的表菌落板照片。Figure 10 is Mat@CS-Pro in
具体实施方式:Detailed ways:
下面结合附图并通过具体实施例对本发明的技术方案作进一步的说明。The technical solutions of the present invention will be further described below in conjunction with the accompanying drawings and through specific embodiments.
以下实施例仅是示例性的,仅能用来解释和说明本发明的技术方案,而不能解释为是对本发明技术方案的限制。The following examples are only exemplary, and can only be used to explain and illustrate the technical solution of the present invention, but cannot be construed as a limitation to the technical solution of the present invention.
本发明技术方案提供可一种环境友好的pH响应型Mat@CS-Pro纳米胶囊防污剂及其制备方法,以天然有机苦参碱(matrine,Mat)作为芯材,以天然高分子壳聚糖(chitosan,CS)作为壁材,通过微乳液聚合法制备CS包封Mat的微胶囊,并通过冷浴搅拌的方法将D-脯氨酸(D-Proline)固定到胶囊上,最终制备出高性能的智能pH响应抗菌/生物膜防污剂。The technical scheme of the present invention provides an environmentally friendly pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method, using natural organic matrine (matrine, Mat) as the core material, and using natural polymer shell Sugar (chitosan, CS) was used as the wall material, and the CS-encapsulated Mat microcapsules were prepared by microemulsion polymerization, and D-Proline (D-Proline) was fixed on the capsules by stirring in a cold bath, and finally prepared High-performance smart pH-responsive antimicrobial/biofilm antifouling agent.
这里,CS是由甲壳类生物中含有的甲壳素脱乙酰反应后得到的产物,具有良好的抗菌性。同时,CS作为多糖拥有丰富的生物性能和物理性能,包括生物可降解性、生物相容性和无毒等。由其作为外壳所制备的微胶囊具有典型的pH响应性。在酸性条件下,CS侧链中所携带的大量氨基带正电荷,CS的氨基发生质子化,由于静电排斥作用,微胶囊膨胀而孔道打开和扩大;当溶液环境为碱性时,则发生去质子化,导致微胶囊收缩,孔道缩小甚至关闭。通常海洋环境呈碱性,而环境中的细菌在基体定植后代谢产生的乳酸等分泌物会导致周围环境pH降低,促进微胶囊膨胀,加速药物的释放,起到了杀菌效果;反之,当周围细菌很少,则海洋环境呈现碱性,微胶囊收缩,从而药物被CS包裹而储存起来,大大延长了其使用寿命。由此可见,使用CS所制备的微胶囊能够储存和可持续释放药物,实现抗菌剂的延缓释放和pH智能响应杀菌,同时提高药物的稳定性,实现药物的最大杀菌作用。除此之外,CS还能够生物降解,并且对环境无污染,对生物体无毒,实现了绿色环保的目标,在食品安全、公共卫生和医疗器械等领域有良好的应用前景。Here, CS is a product obtained after the deacetylation reaction of chitin contained in crustaceans, and has good antibacterial properties. At the same time, as a polysaccharide, CS has rich biological and physical properties, including biodegradability, biocompatibility and non-toxicity. The microcapsules prepared with it as the shell have typical pH responsiveness. Under acidic conditions, a large number of amino groups carried in the CS side chain are positively charged, and the amino groups of CS are protonated. Due to electrostatic repulsion, the microcapsules expand and the pores open and expand; when the solution environment is alkaline, desorption occurs. Protonation causes the microcapsules to shrink and the pores to shrink or even close. Usually the marine environment is alkaline, and the secretions such as lactic acid produced by the metabolism of bacteria in the environment after colonization on the substrate will reduce the pH of the surrounding environment, promote the expansion of microcapsules, accelerate the release of drugs, and play a bactericidal effect; on the contrary, when the surrounding bacteria Rarely, the marine environment is alkaline, and the microcapsules shrink, so that the drug is wrapped by CS and stored, which greatly prolongs its service life. It can be seen that the microcapsules prepared by using CS can store and release drugs continuously, realize the delayed release of antibacterial agents and pH intelligent response to sterilization, improve the stability of drugs at the same time, and realize the maximum bactericidal effect of drugs. In addition, CS is also biodegradable, non-polluting to the environment, and non-toxic to organisms. It has achieved the goal of green environmental protection and has good application prospects in the fields of food safety, public health, and medical equipment.
而Mat是由豆科植物苦参的干燥根、植株、果实经乙醇等有机溶剂提取制成的一种生物碱,其有多方面的药理作用和功效,如抗菌、抗炎、抗风湿、抗肿瘤、抗过敏、抗病毒、抗寄生虫、抗心律失常、消肿利尿、免疫及生物反应调节作用等。Mat是一种植源性农药,具有特定性、天然性的特点,且其只对特定的生物产生作用,在大自然中能迅速分解,最终产物为水和二氧化碳。因为有多种化学物质共同作用,使其不易导致有害物产生抗药性,能长期使用。因而Mat与一般高毒、高残留的化学农药有着明显区别,是十分绿色、环保的。但由于其内有内酰胺结构,在碱性环境中易发生皂化反应使结构被破坏,因此增加Mat的稳定性,使其减少暴露在碱性环境中是增加其抗菌稳定性及长效性的关键。And Mat is a kind of alkaloid that is made by extracting the dry roots, plants and fruits of Sophora flavescens through ethanol and other organic solvents. It has many pharmacological effects and effects, such as antibacterial, anti-inflammatory, anti-rheumatic, anti- Tumor, anti-allergy, anti-virus, anti-parasite, anti-arrhythmia, swelling and diuresis, immune and biological response regulation, etc. Mat is a plant-derived pesticide with specific and natural characteristics, and it only acts on specific organisms. It can be rapidly decomposed in nature, and the final products are water and carbon dioxide. Because a variety of chemical substances work together, it is not easy to cause harmful substances to develop drug resistance, and can be used for a long time. Therefore, Mat is obviously different from general high-toxicity and high-residue chemical pesticides, and is very green and environmentally friendly. However, due to the lactam structure in it, it is easy to undergo saponification reaction in alkaline environment and the structure will be destroyed. Therefore, increasing the stability of Mat and reducing its exposure to alkaline environment is to increase its antibacterial stability and long-term effect. The essential.
D-氨基酸作为L-氨基酸的对映体由消旋体产生。由于其可降解、无毒和来源,它们被广泛用于药物合成、酶结构和功能分析以及杀菌剂应用。而申请人经过多年的实验研究发现,将其应用于防污剂中通过抑制生物膜的形成来达到防污的目的是可行的。D-amino acids are produced as enantiomers of L-amino acids from racemates. Due to their degradability, nontoxicity and origin, they are widely used in drug synthesis, enzyme structure and function analysis, and fungicide applications. After years of experimental research, the applicant found that it is feasible to apply it to antifouling agents to achieve the purpose of antifouling by inhibiting the formation of biofilm.
由此,本发明选用Mat作为天然抗菌剂,通过包覆CS,制备出pH响应抑菌微胶囊后将D-Proline固定到胶囊表面,制备环境友好型的pH智能响应的抗菌/生物膜防污胶囊。当溶液环境为酸性时,胶囊CS上的氨基发生质子化,由于静电排斥作用,Mat@CS微胶囊膨胀而孔道打开和扩大,抗菌剂从胶囊中释放杀菌,同时D-proline由于小于等电点而带正电,与CS带同种电荷,因而两者产生静电互斥作用,促进了D-Proline的释放进而抑制生物膜的形成。当溶液环境为碱性时,则发生去质子化,导致微胶囊收缩,孔道缩小和关闭,抗菌剂不释放,Mat被封闭起来,减小了Mat的内酰胺结构直接暴露于碱性环境中发生皂化反应而导致变性的可能,使得Mat在胶囊内长期稳定保存,提高了Mat的稳定性,同时D-Proline因在碱性环境中的所带电荷与CS一样均为负电荷,因此在碱性环境中D-Proline亦能释放抑制生物膜的形成进行防污。通常,细菌代谢产生的乳酸等分泌物会导致周围环境pH降低,促进微胶囊膨胀,加速Mat和D-Proline的释放,起到了杀菌效果;反之,当周围细菌很少,则环境呈碱性,使微胶囊收缩,从而可以储存Mat。由此可见,在海洋环境中Mat@CS-Pro微胶囊能够稳定存在,并有效储存杀菌剂成分。当细菌富集、定植并引起微环境pH降低时,Mat@CS-Pro微胶囊能够有效释放Mat和D-proline,实现防污剂杀菌协同抑制生物膜形成的目的,而所添加的Mat、CS、D-Proline均能够生物降解,并且对环境无污染,对生物体无毒,实现了绿色环保防污剂的目标。Therefore, the present invention selects Mat as a natural antibacterial agent, prepares pH-responsive antibacterial microcapsules by coating CS, and then fixes D-Proline on the surface of the capsules to prepare environmentally friendly pH smart-responsive antibacterial/biofilm antifouling capsule. When the solution environment is acidic, the amino group on the capsule CS is protonated, and due to electrostatic repulsion, the Mat@CS microcapsule expands and the pores open and expand, and the antibacterial agent is released from the capsule to kill bacteria. At the same time, D-proline is less than the isoelectric point It is positively charged and has the same charge as CS, so the two produce electrostatic mutual repulsion, which promotes the release of D-Proline and inhibits the formation of biofilm. When the solution environment is alkaline, deprotonation occurs, causing the microcapsules to shrink, the pores to narrow and close, the antibacterial agent is not released, and Mat is blocked, reducing the lactam structure of Mat directly exposed to the alkaline environment. The possibility of denaturation caused by saponification makes Mat stable for long-term storage in the capsule, which improves the stability of Mat. In the environment, D-Proline can also be released to inhibit the formation of biofilm for antifouling. Usually, secretions such as lactic acid produced by bacterial metabolism will reduce the pH of the surrounding environment, promote the expansion of microcapsules, accelerate the release of Mat and D-Proline, and have a bactericidal effect; on the contrary, when there are few surrounding bacteria, the environment is alkaline. The microcapsules are shrunk so that Mat can be stored. It can be seen that Mat@CS-Pro microcapsules can exist stably in the marine environment and effectively store fungicide components. When bacteria are enriched and colonized, and the pH of the microenvironment decreases, Mat@CS-Pro microcapsules can effectively release Mat and D-proline to achieve the purpose of antifouling agent sterilization and synergistic inhibition of biofilm formation, while the added Mat, CS , D-Proline are biodegradable, and have no pollution to the environment and are non-toxic to organisms, achieving the goal of a green and environmentally friendly antifouling agent.
该制备方法包括以下步骤:The preparation method comprises the following steps:
Mat溶于含卵磷脂的无水乙醇中,制备油相,CS溶于无水乙酸制备水相。通过微乳液法制备Mat@CS的O/W结构微胶囊。水相油相混溶后水相开始包覆油相,形成包材为CS,芯材为Mat的胶囊结构,转速100~400rpm条件下搅拌约2h,经透析袋透析,然后冻干保存。将20~40mg的D-Proline溶解于20mL水溶液中,然后加入10~20mg的Mat@CS,在冰浴中以100~400rpm转速搅拌约50h。游离的D-Proline在去离子水溶液中透析消除。Mat@CS-Pro纳米胶囊在-50℃真空冷冻约40h后收集。Mat was dissolved in absolute ethanol containing lecithin to prepare the oil phase, and CS was dissolved in anhydrous acetic acid to prepare the water phase. O/W structured microcapsules of Mat@CS were prepared by microemulsion method. After the water phase and oil phase are miscible, the water phase begins to coat the oil phase, forming a capsule structure with CS as the packaging material and Mat as the core material. Stir for about 2 hours at a speed of 100-400 rpm, dialyze through a dialysis bag, and then freeze-dry for storage. Dissolve 20-40 mg of D-Proline in 20 mL of aqueous solution, then add 10-20 mg of Mat@CS, and stir in an ice bath at 100-400 rpm for about 50 h. Free D-Proline was eliminated by dialysis in deionized aqueous solution. Mat@CS-Pro nanocapsules were collected after vacuum freezing at -50°C for about 40 h.
CS量为10mg,乙酸水溶液(1%,v/v)体积为10~30mL。所述的微乳液方法为:Mat溶液通过液-液均相形核过程形成微液滴,与CS溶液共混后Mat微液滴被包裹在CS内形成微胶囊。此过程中,作为乳化剂的卵磷脂参与液-液形均相形核过程,并实现微胶囊形成过程。最终,根据微乳液法O/W机制自组装形成CS包覆Mat的微胶囊。油/水界面的张力在表面活性剂作用下降,甚至产生瞬时负界面张力,所以体系将自发扩张界面,直至界面张力恢复为零或微小的正值而形成微乳液。The amount of CS is 10 mg, and the volume of aqueous acetic acid (1%, v/v) is 10-30 mL. The microemulsion method is as follows: the Mat solution forms microdroplets through a liquid-liquid homogeneous nucleation process, and after blending with the CS solution, the Mat microdroplets are wrapped in the CS to form microcapsules. In this process, lecithin as an emulsifier participates in the liquid-liquid homogeneous nucleation process and realizes the microcapsule formation process. Finally, CS-coated Mat microcapsules were self-assembled according to the O/W mechanism of the microemulsion method. The tension of the oil/water interface decreases under the action of the surfactant, and even produces a transient negative interfacial tension, so the system will spontaneously expand the interface until the interfacial tension returns to zero or a slightly positive value to form a microemulsion.
CS包覆Mat的包覆结构稳定,在碱性环境中CS包材发生去质子化,胶囊收缩通道紧闭,Mat不释放。因此,可以使Mat碱性的海水环境长期保持稳定。The coating structure of CS-coated Mat is stable. In alkaline environment, the CS coating material is deprotonated, the shrinkage channel of the capsule is tightly closed, and Mat does not release. Therefore, the alkaline seawater environment of Mat can be kept stable for a long period of time.
D-Proline通过静电作用吸附到Mat@CS胶囊表面,在Mat@CS发挥抗菌作用的同时,D-Proline起到抗生物膜形成的特性,实现了pH响应抗菌协同抗生物膜双重作用的海洋防污功能。D-Proline is adsorbed to the surface of Mat@CS capsules through electrostatic interaction. While Mat@CS exerts antibacterial effect, D-Proline has the characteristics of anti-biofilm formation, realizing the dual effect of pH-responsive antibacterial and anti-biofilm marine defense dirty function.
pH响应型Mat@CS-Pro胶囊具有智能pH响应控释作用,增加Mat在海洋环境中的稳定性。在海洋环境中,细菌代谢产生的分泌物会导致局部pH值降低,由于胶囊外壳CS中氨基的质子化过程,使胶囊膨胀释放Mat以杀死细菌,而pH较高时氨基去质子化,胶囊缩小使Mat封闭起来,减小Mat由于内酰胺结构而直接暴露于碱性环境中导致皂化变性的可能,使得Mat在胶囊内长期稳定保存,提高Mat的杀菌稳定性。The pH-responsive Mat@CS-Pro capsule has an intelligent pH-responsive controlled release function, which increases the stability of Mat in the marine environment. In the marine environment, the secretions produced by bacterial metabolism will lead to a decrease in the local pH value. Due to the protonation process of the amino group in the capsule shell CS, the capsule expands and releases Mat to kill the bacteria. Shrinking makes Mat sealed, reducing the possibility of saponification and denaturation of Mat due to direct exposure to alkaline environment due to the lactam structure, making Mat stable for long-term storage in the capsule, and improving the bactericidal stability of Mat.
实施例1Example 1
(1)用微乳液法制备O/W结构的微胶囊溶液。用移液枪取32mg的Mat溶于30mg/mL的含有卵磷脂的无水乙醇(400μL)中,制备油相。将CS(10mg)溶解于20mL乙酸水溶液(1%,v/v)中,制备水相。将油相缓缓倒入水相,室温下,磁力搅拌器以200rpm的转速搅拌混合溶液2h至泛乳光,获得微胶囊溶液。(1) Microcapsule solution with O/W structure was prepared by microemulsion method. Using a pipette, 32 mg of Mat was dissolved in 30 mg/mL absolute ethanol (400 μL) containing lecithin to prepare an oil phase. The aqueous phase was prepared by dissolving CS (10 mg) in 20 mL of aqueous acetic acid (1%, v/v). Slowly pour the oil phase into the water phase, and at room temperature, stir the mixed solution with a magnetic stirrer at a speed of 200 rpm for 2 hours until it becomes opalescent, and a microcapsule solution is obtained.
(2)将微胶囊溶液转移到透析袋中,浸泡在透析液(pH值为7.4的PBS磷酸盐缓冲溶液)中12h,消除游离的Mat。将微胶囊溶液放入冰箱冷冻层冷冻2h,凝固后送入冻干机在-50℃冻干36h后得到微胶囊粉末。(2) Transfer the microcapsule solution to a dialysis bag, and soak in the dialysate (PBS phosphate buffer solution with a pH value of 7.4) for 12 hours to eliminate free Mat. The microcapsule solution was put into the freezer layer of the refrigerator to freeze for 2 hours, and after solidification, it was sent to a freeze dryer at -50° C. for 36 hours to obtain microcapsule powder.
(3)将40mg的D-Proline溶解在20mL水溶液中,然后在溶液中加入20mg的Mat@CS冻干粉,在冰浴中以200rpm的速度搅拌48h。通过在水溶液中透析消除游离的D-Proline。在-50℃真空冷冻36h后收集Mat@CS-Pro纳米胶囊。(3) Dissolve 40 mg of D-Proline in 20 mL of aqueous solution, then add 20 mg of Mat@CS lyophilized powder into the solution, and stir at 200 rpm for 48 h in an ice bath. Free D-Proline was eliminated by dialysis in aqueous solution. Mat@CS-Pro nanocapsules were collected after vacuum freezing at -50°C for 36 h.
(4)采用菌落计数法分析Mat@CS-Pro纳米胶囊的抗菌性能。选择E.coli和S.aureus作为革兰氏阴性和革兰氏阳性菌株的代表,P.aeruginosa作为海洋细菌的代表。每种细菌的初始浓度约为~108CFU/mL。将1mL的E.coli或S.aureus悬浮液注入50mL的LB培养液中,在37℃恒温设备中以120rpm震荡培养18h。将1mL P.aeruginosa悬浮液转接到50mL无菌2216E培养基中,在30℃下振荡培养18h。此后,移取200μL细菌悬液至8mL LB或2216E培养基,培养基内含2mg/mL不同的抗菌剂(即CS、Mat、D-Proline、Mat@CS纳米胶囊、Mat@CS-Pro纳米胶囊)。在37℃或30℃培养18h后,取20μL稀释后的菌悬液涂于固体培养基板上,在相应温度条件下培养过夜。抑菌结果按下式计算:(4) The antibacterial properties of Mat@CS-Pro nanocapsules were analyzed by colony counting method. E.coli and S.aureus were chosen as representatives of Gram-negative and Gram-positive strains, and P.aeruginosa as a representative of marine bacteria. The initial concentration of each bacterium was approximately ~10 8 CFU/mL. Inject 1 mL of E.coli or S.aureus suspension into 50 mL of LB culture medium, and shake and culture at 120 rpm for 18 hours in a constant temperature equipment at 37°C. Transfer 1mL of P.aeruginosa suspension to 50mL sterile 2216E medium, and shake and culture at 30°C for 18h. Thereafter,
式中A为对照组菌落数,B为治疗组菌落数。此外,通过紫外分光光度计在600nm处检测O.D.曲线,作为评估纳米胶囊抗菌性能的参考。In the formula, A is the number of colonies in the control group, and B is the number of colonies in the treatment group. In addition, the O.D. curve was detected at 600 nm by a UV spectrophotometer as a reference for evaluating the antibacterial properties of nanocapsules.
利用紫外分光光度计在600nm处测定其O.D.值,为评价纳米胶囊的抗菌性能提供参考。The O.D. value was measured at 600nm by a UV spectrophotometer, which provided a reference for evaluating the antibacterial properties of nanocapsules.
(5)通过SEM评估Mat@CS-Pro纳米胶囊的抗粘附性能。316L不锈钢试样(1cm×1cm)用于辅助评估制备的纳米胶囊的抗粘附性能。用1200目碳化硅纸打磨试样,然后超声清洗后再用丙酮和乙醇清洗并用N2吹干,使用紫外线对金属试样进行无菌处理。将1mL的E.coli或S.aureus悬浮液加入到50mL无菌LB中,在37℃下以120rpm振荡18h。将1mL的P.aeruginosa悬浮液加入到50mL无菌2216E培养基中,在30℃下以120rpm振荡18h。将每个试样片放入24孔板中,然后注入4mL的LB培养基(含有2mg/mL的Mat@CS或Mat@CS-Pro纳米胶囊)和100μL菌悬液。静置培养1天和3天后,取出样品并用去离子水洗涤以去除金属表面上的自由漂浮细菌,用2.5%(v/v)戊二醛磷酸盐缓冲液固定溶液(PBS,pH 7.4)2h。随后,将每个试样用PBS洗涤3次,用去离子水洗涤3次,并使用30%、50%、70%、90%和100%(v/v)梯度乙醇脱水15分钟。样品喷碳后,通过扫描电镜观察金属表面的细菌膜。(5) The anti-adhesion performance of Mat@CS-Pro nanocapsules was evaluated by SEM. 316L stainless steel samples (1cm×1cm) were used to assist in evaluating the anti-adhesion properties of the prepared nanocapsules. The samples were polished with 1200-mesh silicon carbide paper, then ultrasonically cleaned with acetone and ethanol and dried with N2 , and the metal samples were sterilized using ultraviolet light. Add 1 mL of E.coli or S.aureus suspension into 50 mL of sterile LB and shake at 120 rpm for 18 h at 37 °
此外,使用Live/BacLight TM细菌活力试剂盒进一步分析Mat@CS-Pro纳米胶囊的抗粘附性能。将每个试样浸泡在不同含纳米胶囊的菌悬液中,分别培养1天和3天。然后每个样品用去离子水洗涤,去除金属表面的游离菌,放入干净的24孔板中,在黑暗处染色20分钟。Additionally, using Live/ The BacLight TM Bacterial Viability Kit further analyzed the anti-adhesion properties of Mat@CS-Pro nanocapsules. Each sample was immersed in different bacterial suspensions containing nanocapsules, and cultured for 1 day and 3 days, respectively. Each sample was then washed with deionized water to remove free bacteria on the metal surface, placed in a clean 24-well plate, and stained for 20 minutes in the dark.
(6)将Mat@CS-Pro纳米胶囊悬浮液(2mg/mL)放入透析袋中,分别浸入pH为5、6、7和8的PBS溶液中12h。每小时通过UV-Vis测量透析溶液,220nm处的峰代表Mat。通过DLS检测Mat@CS-Pro纳米胶囊在不同pH的PBS溶液中处理后的大小。(6) Put the Mat@CS-Pro nanocapsule suspension (2 mg/mL) into the dialysis bag and immerse in the PBS solution with
(7)菌落平板法用于评价pH响应的抗菌性能。制备由4mL不同pH的PBS溶液(pH5、6、7、8)和4mL的LB培养基(或2216E)组成的2mg/mL的Mat@CS-Pro纳米胶囊培养基。将每份200μL菌悬液接种到8mL培养基中,在37℃或30℃下培养4h。将20μL稀释的菌悬液铺在固体培养基上,在相应温度下培养18h。培养4h后的每种细菌悬浮液的O.D.也通过600nm的UV-Vis检测,作为另一种评估Mat@CS-Pro纳米胶囊的pH响应抗菌性能的方法的参考。(7) The colony plate method was used to evaluate the antibacterial performance of the pH response. Prepare a 2 mg/mL Mat@CS-Pro nanocapsule medium consisting of 4 mL of PBS solutions of different pH (
实施例2(效果实施例)Embodiment 2 (effect embodiment)
Mat@CS纳米微胶囊的合成与性能测试:Synthesis and performance testing of Mat@CS nanocapsules:
(1)Mat@CS-Pro纳米胶囊的表征(1) Characterization of Mat@CS-Pro nanocapsules
通过透射电镜观察D-Proline固定前后所制备的纳米胶囊表面的结构和形貌如图1所示。由图1可知,O/W微乳液法制备的Mat@CS纳米胶囊粒径均匀,平均粒径约为250nm。固定D-Proline后,胶囊没有出现团聚现象,且粒径略有增大(图1中a、c部分)。然而,Mat@CS-Pro的形态与Mat@CS纳米胶囊不同,后者显示纳米胶囊内部有大量小液滴(图1中b部分)。根据CS、Mat和Mat@CS纳米胶囊的Zeta电位分别为37.8±1.1mV、-16.9±2.4mV和31.9mV可以推断,纳米胶囊中的液滴应该是Mat,因为游离Mat液滴的表面负电荷完全被阳离子CS覆盖。此外,Mat@CS纳米胶囊的表面覆盖了形状不规则的物质(图1中d部分)。D-Proline和Mat@CS-Pro纳米胶囊的Zeta电位分布分别为-7.7±1.1mV和-5.3±0.3mV,表明带负电荷的D-Proline可以固定在Mat@CS纳米胶囊的表面。因此,D-Proline被固定在Mat@CS纳米胶囊的表面,Mat@CS-Pro纳米胶囊的直径约为280nm。The surface structure and morphology of the prepared nanocapsules before and after D-Proline immobilization were observed by transmission electron microscopy, as shown in Figure 1. It can be seen from Figure 1 that the Mat@CS nanocapsules prepared by the O/W microemulsion method have a uniform particle size, with an average particle size of about 250 nm. After immobilizing D-Proline, the capsules did not agglomerate, and the particle size increased slightly (parts a and c in Figure 1). However, the morphology of Mat@CS-Pro is different from that of Mat@CS nanocapsules, which shows a large number of small droplets inside the nanocapsules (part b in Fig. 1). According to the zeta potentials of CS, Mat and Mat@CS nanocapsules are 37.8 ± 1.1 mV, -16.9 ± 2.4 mV and 31.9 mV, respectively, it can be inferred that the droplets in the nanocapsules should be Mat, because the surface of free Mat droplets is negatively charged completely covered by cationic CS. In addition, the surface of Mat@CS nanocapsules is covered with irregularly shaped substances (part d in Fig. 1). The zeta potential distributions of D-Proline and Mat@CS-Pro nanocapsules were -7.7 ± 1.1 mV and -5.3 ± 0.3 mV, respectively, indicating that negatively charged D-Proline could be immobilized on the surface of Mat@CS nanocapsules. Therefore, D-Proline was immobilized on the surface of Mat@CS nanocapsules, and the diameter of Mat@CS-Pro nanocapsules was about 280 nm.
CS、Mat和所制备的Mat@CS纳米胶囊的FTIR如图2中a部分所示。对于CS谱线,位于3500-3200cm-1的宽峰属于N-H和OH伸缩振动。1157cm-1和1091cm-1峰属于C-O-C伸缩振动。对于Mat谱线,2935cm-1和2853cm-1峰属于CH2中的C-H伸缩振动,1635cm-1峰属于C=O伸缩振动。Mat@CS-Proline纳米胶囊产物谱线的特征与CS谱线相似。图中Mat@CS谱线上也出现了约3500-3200cm-1的宽峰,属于N-H和O-H的伸缩振动。此外,Mat@CS上出现了1157cm-1的峰,它属于C-O-C的伸缩振动。而谱线Mat@CS中的1085cm-1峰(C-O-C伸缩振动)对应于CS谱图上的1019cm-1峰,说明所制备的胶囊中存在CS。同时在Mat@CS中也可以找到Mat的相关特征峰,如谱线谱线中因C=O伸缩振动而出现的1635cm-1峰与纯的Mat峰位一致,且其强度弱于Mat谱线。Mat谱线中由C-H伸缩振动而出现的2935cm-1和2853cm-1峰位分别对应到Mat@CS的2930cm-1和2858cm-1上,且CS上的由C-H伸缩振动引起的2875cm-1峰则被这两个峰所覆盖。也就是说,Mat也同样存在于所制备的纳米胶囊中。此外,位于1737cm-1的新峰表明CS和Mat之间存在H键作用。结合图1所示的TEM结果,表明成功合成了Mat@CS纳米胶囊。The FTIR of CS, Mat and the as-prepared Mat@CS nanocapsules are shown in part a of Fig. 2. For the CS line, the broad peaks located at 3500-3200 cm -1 belong to NH and OH stretching vibrations. The 1157cm -1 and 1091cm -1 peaks belong to COC stretching vibration. For the Mat spectrum, the peaks at 2935cm -1 and 2853cm -1 belong to CH stretching vibration in CH2, and the peak at 1635cm -1 belongs to C=O stretching vibration. The characteristics of the product spectrum of Mat@CS-Proline nanocapsules are similar to the CS spectrum. A broad peak at about 3500-3200cm -1 also appears on the Mat@CS spectrum in the figure, which belongs to the stretching vibration of NH and OH. In addition, a peak at 1157 cm -1 appears on Mat@CS, which belongs to the stretching vibration of COC. The 1085cm -1 peak (COC stretching vibration) in the Mat@CS spectrum corresponds to the 1019cm -1 peak in the CS spectrum, indicating that CS exists in the prepared capsules. At the same time, Mat related characteristic peaks can also be found in Mat@CS, such as the 1635cm -1 peak in the spectral line due to C=O stretching vibration is consistent with the pure Mat peak, and its intensity is weaker than that of the Mat spectral line . The 2935cm -1 and 2853cm -1 peaks in the Mat line due to the CH stretching vibration correspond to the 2930cm -1 and 2858cm -1 of Mat@CS respectively, and the 2875cm -1 peak on the CS caused by the CH stretching vibration covered by these two peaks. That is to say, Mat also exists in the prepared nanocapsules. In addition, a new peak located at 1737 cm indicates the existence of H-bonding interactions between CS and Mat. Combined with the TEM results shown in Figure 1, it indicated that Mat@CS nanocapsules were successfully synthesized.
胶囊负载D-Proline后对产物成分进行FTIR分析,结果如图2中b部分所示。对于D-Proline的谱线谱线,3051cm-1和2979cm-1的峰分别是由C-H键的不对称伸缩和对称伸缩振动产生。在D-Proline谱线中位于1600~1450cm-1谱线的峰与骨架环振动有关,而在合成的Mat@CS-Pro纳米胶囊谱线上的相似位置也出现了强峰。同时,在D-Proline谱线上由CH2的摇摆振动所引起的848cm-1和791cm-1处的峰分别对应到了Mat@CS-Pro谱线的856cm-1和773cm-1峰位上。谱线谱线谱线此外,Mat@CS纳米胶囊的由C-O-C振动引起的1164cm-1和1085cm-1处的峰也出现在Mat@CS-Pro谱线上。结合图1所示的TEM结果,表明D-proline成功地固定在了Mat@CS-Pro纳米胶囊上。After the capsule was loaded with D-Proline, the product components were analyzed by FTIR, and the results are shown in part b of Figure 2. For the spectral line of D-Proline, the peaks at 3051cm -1 and 2979cm -1 are produced by the asymmetric stretching and symmetric stretching vibrations of CH bond respectively. The peaks located at 1600-1450 cm -1 in the D-Proline spectrum are related to the vibration of the skeleton ring, and there are strong peaks at similar positions on the spectrum of the synthesized Mat@CS-Pro nanocapsules. At the same time, the peaks at 848cm -1 and 791cm -1 caused by the rocking vibration of CH 2 on the D-Proline line correspond to the peak positions at 856cm -1 and 773cm -1 of the Mat@CS-Pro line, respectively. Spectral lines Spectral lines In addition, the peaks at 1164cm -1 and 1085cm -1 of Mat@CS nanocapsules caused by COC vibration also appeared on Mat@CS-Pro spectral lines. Combined with the TEM results shown in Figure 1, it shows that D-proline was successfully immobilized on Mat@CS-Pro nanocapsules.
(2)Mat@CS-Pro纳米胶囊的抗菌性能表征(2) Characterization of antibacterial properties of Mat@CS-Pro nanocapsules
图3为CS、Mat和Mat@CS纳米胶囊对E.coli、S.aureus和P.aeruginosa的菌落计数和抑菌效果图。在图3中a部分中,经过这三种药品处理后的细菌数量较空白对照组(379CFU)显著下降,说明CS、Mat和Mat@CS纳米胶囊对这三种菌株均有显著的抗菌作用。图3中b部分显示了三种药品分别对E.coli、S.aureus和P.aeruginosa的抑菌作用,其中对P.aeruginosa的杀菌率分别超过了87.71%、77.90%和73.39%。值得注意的是,纯Mat和Mat@CS纳米胶囊对革兰氏阳性菌的抑菌效果优于革兰氏阴性菌,对P.aeruginosa的抑菌效果最差。具体来说,Mat和Mat@CS对P.aeruginosa的抑菌率分别为78.02%和89.16%,与S.aureus相应杀菌率相比分别降低了15.06%和5.39%。与纯Mat相比,Mat@CS纳米胶囊对E.coli、S.aureus和P.aeruginosa表现出更好的抗菌性能。P.aeruginosa菌落分别减少8CFU、6CFU和39CFU。从图3中b部分的结果来看,Mat@CS纳米胶囊对以上三种菌的抑菌率分别提高到89.71%、94.55%和89.16%。因此,经CS包覆后,Mat@CS纳米胶囊的抗菌性能显著提高。Figure 3 is a graph of the colony count and antibacterial effect of CS, Mat and Mat@CS nanocapsules on E.coli, S.aureus and P.aeruginosa. In part a of Figure 3, the number of bacteria after the treatment of these three drugs was significantly lower than that of the blank control group (379CFU), indicating that CS, Mat and Mat@CS nanocapsules have significant antibacterial effects on these three strains. Part b of Figure 3 shows the antibacterial effects of the three drugs on E.coli, S.aureus and P.aeruginosa respectively, and the bactericidal rates on P.aeruginosa exceeded 87.71%, 77.90% and 73.39% respectively. Notably, the antibacterial effect of pure Mat and Mat@CS nanocapsules on Gram-positive bacteria was better than that on Gram-negative bacteria, and the antibacterial effect on P.aeruginosa was the worst. Specifically, the antibacterial rates of Mat and Mat@CS against P.aeruginosa were 78.02% and 89.16%, respectively, which were 15.06% and 5.39% lower than those of S.aureus, respectively. Compared with pure Mat, Mat@CS nanocapsules exhibited better antibacterial properties against E.coli, S.aureus, and P.aeruginosa. P. aeruginosa colonies were reduced by 8CFU, 6CFU and 39CFU, respectively. From the results in part b of Figure 3, the antibacterial rates of Mat@CS nanocapsules against the above three bacteria increased to 89.71%, 94.55% and 89.16%, respectively. Therefore, the antibacterial performance of Mat@CS nanocapsules was significantly improved after being coated with CS.
菌落计数法进一步显示了Mat@CS-Pro纳米胶囊的抗菌效果,结果如图4所示。如图4中b部分所示,纯D-Proline的抗菌效果并不理想。E.coli、S.aureus和P.aeruginosa的抑菌率分别约为57.71%、49.96%和66.55%。然而,在固定D-Proline后,Mat@CS-Pro纳米胶囊对E.coli和P.aeruginosa的抗菌率分别达到92.85%和96.28%。然而在引入D-Proline后,Mat@CS-Pro纳米胶囊对S.aureus的抑菌率从94.55%降低到87.75%,这可能是因为D-Proline的纳米胶囊结构对S.aureus抑菌性差所致。在Mat@CS-Pro表面包覆D-Proline后,其可能会阻碍Mat的释放,而且位于表面的D-Proline不能提供显着的抑菌作用,导致Mat@CS-Pro的抗菌性能略有减小。总体而言,引入D-Proline后,Mat@CS-Pro纳米胶囊对革兰氏阳性菌几乎可以保持出色的抗菌性能,甚至对革兰氏阴性菌发挥出更优异的抗菌性能。The colony counting method further showed the antibacterial effect of Mat@CS-Pro nanocapsules, and the results are shown in Figure 4. As shown in part b of Figure 4, the antibacterial effect of pure D-Proline is not satisfactory. The antibacterial rates of E.coli, S.aureus and P.aeruginosa were about 57.71%, 49.96% and 66.55%, respectively. However, after immobilizing D-Proline, the antibacterial rates of Mat@CS-Pro nanocapsules against E.coli and P.aeruginosa reached 92.85% and 96.28%, respectively. However, after the introduction of D-Proline, the antibacterial rate of Mat@CS-Pro nanocapsules against S.aureus decreased from 94.55% to 87.75%, which may be due to the poor antibacterial effect of the nanocapsule structure of D-Proline on S.aureus. Sincerely. After the surface of Mat@CS-Pro is coated with D-Proline, it may hinder the release of Mat, and the D-Proline on the surface cannot provide significant antibacterial effect, resulting in a slight decrease in the antibacterial performance of Mat@CS-Pro. Small. Overall, after the introduction of D-Proline, Mat@CS-Pro nanocapsules can almost maintain excellent antibacterial performance against Gram-positive bacteria, and even exhibit better antibacterial performance against Gram-negative bacteria.
经Mat@CS-Pro纳米胶囊杀菌处理后,用扫描电镜观察E.coli、S.aureus和P.aeruginosa的形态。与对照组相比,细菌的细胞膜几乎失去了完整的结构,表明纳米胶囊对细菌细胞造成了不可逆的损伤。此外,与S.aureus的形态相比,E.coli和P.aeruginosa的细胞表面覆盖有大量有机物,这证明Mat@CS-Pro纳米胶囊对革兰氏阴性菌株的影响比对革兰氏阳性菌株的影响更强。这些结果与图4所示的菌落计数结果一致。After being sterilized by Mat@CS-Pro nanocapsules, the morphology of E.coli, S.aureus and P.aeruginosa was observed by scanning electron microscope. Compared with the control group, the cell membrane of the bacteria almost lost its complete structure, indicating that the nanocapsules caused irreversible damage to the bacterial cells. In addition, the cell surfaces of E.coli and P.aeruginosa were covered with a large amount of organic matter compared with the morphology of S.aureus, which demonstrated that Mat@CS-Pro nanocapsules were more effective on Gram-negative strains than on Gram-positive strains. influence is stronger. These results are consistent with the colony count results shown in Figure 4.
(3)Mat@CS-Pro纳米胶囊的生物膜分散性(3) Biofilm dispersion of Mat@CS-Pro nanocapsules
通过SEM评估Mat@CS和Mat@CS-Pro纳米胶囊作用3天后对生物膜形成的影响。对于对照组,金属表面附着的细菌最多,并出现聚集现象(图6中a-a2部分)。与Mat@CS纳米胶囊一起培养后,基体表面细菌细胞数量和聚集现象略有减少(图6中b-b2部分)。在图6中c-c2部分中,将D-Proline引入Mat@CS纳米胶囊后,细菌个数和聚集现象进一步减少。由图可见,大部分细菌细胞以单细胞形式随机分散在基材表面。而且可以看到细菌聚集区域的细菌形态与对照组明显不同,当培养基中没有添加纳米胶囊时,细菌具有完整的细胞形态并且细胞膜具有清晰的边缘。然而对于添加了Mat@CS-Pro的基材表面形貌,尤其是聚集区,细菌形态与图5中a1-c1部分相似,即细菌团聚起来(图6中c-c2部分)。The effect of Mat@CS and Mat@CS-Pro nanocapsules on biofilm formation after 3 days was evaluated by SEM. For the control group, the bacteria attached to the metal surface were the most, and aggregation phenomenon occurred (part aa 2 in Figure 6). After co-cultured with Mat@CS nanocapsules, the number of bacterial cells and aggregation on the surface of the substrate were slightly reduced (part bb 2 in Figure 6). In the cc 2 part in Figure 6, after introducing D-Proline into the Mat@CS nanocapsules, the number of bacteria and the aggregation phenomenon were further reduced. It can be seen from the figure that most of the bacterial cells are randomly scattered on the surface of the substrate in the form of single cells. And it can be seen that the bacterial morphology in the bacterial aggregation area is significantly different from that of the control group. When no nanocapsules were added to the medium, the bacteria had a complete cell morphology and the cell membrane had a clear edge. However, for the surface morphology of the substrate added with Mat@CS-Pro, especially the aggregation area, the bacterial morphology is similar to the a 1 -c 1 part in Figure 5, that is, the bacteria are aggregated (the cc 2 part in Figure 6).
培养3天后,用IPCM对形成的生物膜进行评估,结果如图7所示。视野中绿色和红色区域分别代表活菌和死菌。由图可知,对照组中几乎全部呈现绿色,表明316L不锈钢片对这三种细菌均未表现出毒性,细菌能够在基体表面存活并形成完整、均匀的生物膜。其中,E.coli、S.aureus和P.aeruginosa生物膜的厚度分别约为30μm、39μm和48μm(图6中a-a2部分)。用Mat@CS和Mat@CS-Pro纳米胶囊培养后视野中出现许多红色区域,表明出现大量死菌。此外,在Mat@CS纳米胶囊中引入D-Proline后,绿色区域比例进一步减少,表明Mat@CS-Pro纳米胶囊的抗菌效果优于Mat@CS纳米胶囊,这与图4中的结果一致。在图6中c-c2部分,与Mat@CS-Pro纳米胶囊培养3天后,形成的E.coli、S.aureus和P.aeruginosa的生物膜厚度分别约为20μm、10μm和28μm。Mat@CS-Pro纳米胶囊的生物被膜分散能力明显提高,与对照组相比,E.coli、S.aureus和P.aeruginosa生物膜分别减少约33%、74%和42%。因此,在现有抗菌性能的基础上,引入D-Proline有助于提高防污剂的生物膜分散性能。After 3 days of culture, the formed biofilm was evaluated by IPCM, and the results are shown in Figure 7. The green and red areas in the field of view represent live and dead bacteria, respectively. It can be seen from the figure that almost all of the control group are green, indicating that the 316L stainless steel sheet has no toxicity to these three bacteria, and the bacteria can survive on the surface of the substrate and form a complete and uniform biofilm. Among them, the biofilm thicknesses of E.coli, S.aureus, and P.aeruginosa were about 30 μm, 39 μm, and 48 μm, respectively (aa 2 in Figure 6). After culturing with Mat@CS and Mat@CS-Pro nanocapsules, many red areas appeared in the visual field, indicating a large number of dead bacteria. In addition, after introducing D-Proline into Mat@CS nanocapsules, the proportion of green area was further reduced, indicating that the antibacterial effect of Mat@CS-Pro nanocapsules was better than that of Mat@CS nanocapsules, which was consistent with the results in Fig. 4. In the cc 2 part in Figure 6, after 3 days of culture with Mat@CS-Pro nanocapsules, the biofilm thicknesses of E.coli, S.aureus and P.aeruginosa formed were about 20 μm, 10 μm and 28 μm, respectively. The biofilm dispersion ability of Mat@CS-Pro nanocapsules was significantly improved, and the biofilms of E.coli, S.aureus, and P.aeruginosa were reduced by about 33%, 74%, and 42%, respectively, compared with the control group. Therefore, on the basis of the existing antibacterial properties, the introduction of D-Proline helps to improve the biofilm dispersion properties of antifouling agents.
(4)Mat@CS-Pro纳米胶囊的pH控制释放和抗菌特性(4) pH-controlled release and antibacterial properties of Mat@CS-Pro nanocapsules
用TEM表征在pH 5和pH 8的PBS溶液中处理后的Mat@CS纳米胶囊和Mat@CS-Pro纳米胶囊的形貌和结构。在酸性条件下,CS的-NH2基团转化为-NH3 +,导致在体系中产生正电荷和内部静电斥力。因此,在pH值为5的条件下浸泡后,Mat@CS纳米胶囊从280nm膨胀到430nm左右(图8中a部分)。在海洋环境(pH 8)中,由于CS氨基的去质子化,Mat@CS纳米胶囊收缩到约220nm,如图8中b部分所示。固定D-Proline后,纳米胶囊的pH响应特性仍然存在。在图8中c部分和8中d部分,在碱性和酸性PBS溶液中处理后的Mat@CS-Pro纳米胶囊的直径分别约为475nm和234nm。结果表明,Mat@CS-Pro纳米胶囊具有pH响应性,纳米胶囊的直径可以随环境pH的变化而变化。The morphology and structure of Mat@CS nanocapsules and Mat@CS-Pro nanocapsules treated in
通过UV-Vis和DLS分析确定了Mat@CS-Pro纳米胶囊的pH控制释放行为和机理。根据标准曲线(图9中a部分)计算的Mat从Mat@CS-Pro纳米胶囊中的释放浓度如图9中b部分所示。在碱性条件下,Mat的释放量维持在较低的水平,从初始的5.1ppm到10h后的7.1ppm。同时,DLS结果表明,Mat@CS-Pro纳米胶囊在pH为8的PBS溶液中浸泡后的尺寸最小,约为236±13nm。相反,Mat在酸性溶液中的释放量持续增加,在pH 5和pH 6溶液中浸泡10h后,Mat的浓度分别约为28.5ppm和23.5ppm。与初始状态相比,Mat的释放浓度分别增加了16.8ppm和10.3ppm。在图9中c部分,在pH 5和pH 6溶液中处理后的纳米胶囊的直径分别为478±18nm和396±21nm,这与图8的结果一致。与在pH 8条件下处理的相应纳米胶囊相比,纳米胶囊的直径分别增加了约242nm和160nm。在pH为7时,10h内Mat的释放量呈上升趋势,1h后释放量为7.6ppm,5h后为9.4ppm,10h后进一步增加至10.1ppm。以上结果表明,固定D-Proline后Mat@CS-Pro纳米胶囊的pH响应特性不受限制。随着PBS溶液pH的升高,Mat的释放行为和纳米胶囊的尺寸减小。The pH-controlled release behavior and mechanism of Mat@CS-Pro nanocapsules were determined by UV-Vis and DLS analysis. The release concentration of Mat from Mat@CS-Pro nanocapsules calculated according to the standard curve (part a in Figure 9) is shown in part b in Figure 9. Under alkaline conditions, the release of Mat was maintained at a low level, from the initial 5.1ppm to 7.1ppm after 10h. At the same time, DLS results showed that the size of Mat@CS-Pro nanocapsules after soaking in PBS solution with
通过UV-Vis评估Mat@CS-Pro纳米胶囊在不同pH培养基中对E.coli、S.aureus和P.aeruginosa的细菌生长状态的影响。细菌浓度随O.D.值的增加而增大。从图9中d部分可以看出这三种细菌菌株的O.D.值随着培养基pH值的增加而增加,表明随着pH值的增加,培养基中的细菌数量也增加。具体来说,在pH 5、6、7和8条件下培养后,E.coli的O.D.值分别约为0.69±0.02、0.70±0.02、0.75±0.01和0.77±0.02。在图10中a到d部分,菌落平板照片的结果与O.D.数据一致,即细菌菌落数量随着环境pH的增加而明显增加。S.aureus的O.D.值变化趋势与E.coli相似,依次为0.68±0.01、0.69±0.01、0.72±0.01、0.72±0.01,这一结果与图10中a1-d1部分一致。至于P.aeruginosa组,O.D.值从pH 5条件下的0.27±0.01增加到pH 8条件下的0.45±0.05。在图10中a2-d2部分,在pH 7和8条件下培养后,固体培养基上散布的菌落较多,但在pH 6和7条件下培养后,固体培养基上的菌落较少。这些结果表明Mat@CS-Pro的抗菌性能随着环境pH值的增加而降低。结合图9中b和c部分的结果可见,由于纳米胶囊在酸性环境下尺寸较大且易于释放Mat,因此Mat@CS-Pro纳米胶囊在酸性环境中具有更好的抗菌性能。The effects of Mat@CS-Pro nanocapsules on the bacterial growth status of E.coli, S.aureus and P.aeruginosa in different pH media were evaluated by UV-Vis. The bacterial concentration increased with the increase of OD value. From part d of Figure 9, it can be seen that the OD values of the three bacterial strains increase with the increase of the pH value of the medium, indicating that the number of bacteria in the medium also increases with the increase of the pH value. Specifically, the OD values of E. coli were about 0.69±0.02, 0.70±0.02, 0.75±0.01 and 0.77±0.02 after cultured at
综上,本发明技术方案首先将苦参碱(Mat)溶于含卵磷脂的无水乙醇中制备油相,将壳聚糖(CS)溶于无水乙酸制备水相,通过微乳液法制备O/W结构的微胶囊溶液,胶囊呈球状分布。通过CS的包裹,使在海洋这种碱性条件下稳定性较差的Mat保持杀菌活性。由于胶囊外壳CS中氨基的质子化和去质子化过程,Mat@CS微胶囊膨胀或收缩,孔道打开或关闭,Mat从胶囊中释放或储存起来不释放。与碱性环境相比,所制备的抑菌胶囊在酸性溶液中具有更加出色的抗菌性能,酸性环境中CS上的氨基发生质子化,分子间发生静电互斥作用,微胶囊膨胀孔道打开释放药物进行杀菌。CS在碱性条件下的氨基去质子化可防止Mat释放,增加胶囊在碱性环境中的稳定性。CS与D-Proline的等电点相近,在酸性或碱性环境下,两者Zeta电位相同,分子间发生静电互斥作用。这加速了D-Proline的释放,使得Mat@CS-Proline在释放Mat抗菌的同时也释放D-Proline,从而实现了具备pH相应功能的抗菌、抗生物膜双重功效的纳米防污微胶囊。本发明的材料环境友好、具有优越的抑菌作用,为探索海洋领域智能pH响应型防污剂的研究提供了思路。In summary, the technical scheme of the present invention first dissolves matrine (Mat) in dehydrated alcohol containing lecithin to prepare an oil phase, dissolves chitosan (CS) in anhydrous acetic acid to prepare an aqueous phase, and prepares it by a microemulsion method Microcapsule solution with O/W structure, the capsules are distributed in a spherical shape. Through the encapsulation of CS, Mat, which is less stable in the alkaline conditions of the ocean, maintains bactericidal activity. Due to the protonation and deprotonation process of the amino groups in the capsule shell CS, the Mat@CS microcapsules swell or shrink, the pores open or close, and Mat is released from the capsules or stored without release. Compared with the alkaline environment, the prepared antibacterial capsules have better antibacterial properties in acidic solution. In acidic environment, the amino group on CS is protonated, and electrostatic mutual repulsion occurs between molecules, and the expansion pores of the microcapsules are opened to release the drug. Sterilize. The deprotonation of the amino group of CS under alkaline conditions prevents the release of Mat and increases the stability of the capsules in an alkaline environment. The isoelectric points of CS and D-Proline are similar. In acidic or alkaline environment, the zeta potentials of both are the same, and electrostatic mutual repulsion occurs between the molecules. This accelerates the release of D-Proline, making Mat@CS-Proline release D-Proline while releasing Mat antibacterial, thus realizing the nano-antifouling microcapsules with pH-corresponding functions of antibacterial and anti-biofilm dual functions. The material of the invention is environmentally friendly and has superior antibacterial effect, and provides ideas for exploring the research of intelligent pH-responsive antifouling agents in the marine field.
需要说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention without limitation, although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solutions of the present invention can be carried out Modifications or equivalent replacements without departing from the spirit and scope of the technical solution of the present invention shall be covered by the claims of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210636699.5A CN115999462A (en) | 2022-06-07 | 2022-06-07 | A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210636699.5A CN115999462A (en) | 2022-06-07 | 2022-06-07 | A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115999462A true CN115999462A (en) | 2023-04-25 |
Family
ID=86017942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210636699.5A Pending CN115999462A (en) | 2022-06-07 | 2022-06-07 | A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115999462A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116676044A (en) * | 2023-08-03 | 2023-09-01 | 北京科技大学 | Antibacterial anti-adhesion hydrophobic antifouling coating and preparation method thereof |
-
2022
- 2022-06-07 CN CN202210636699.5A patent/CN115999462A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116676044A (en) * | 2023-08-03 | 2023-09-01 | 北京科技大学 | Antibacterial anti-adhesion hydrophobic antifouling coating and preparation method thereof |
CN116676044B (en) * | 2023-08-03 | 2023-10-27 | 北京科技大学 | Antibacterial anti-adhesion hydrophobic antifouling coating and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | pH-responsive Capsaicin@ chitosan nanocapsules for antibiofouling in marine applications | |
Sureshkumar et al. | Magnetic antimicrobial nanocomposite based on bacterial cellulose and silver nanoparticles | |
Hao et al. | pH responsive antifouling and antibacterial multilayer films with Self-healing performance | |
Pan et al. | Preparation nanoparticle by ionic cross-linked emulsified chitosan and its antibacterial activity | |
Koo et al. | Improvement of the stability of Lactobacillus casei YIT 9018 by microencapsulation using alginate and chitosan | |
EP1899451B1 (en) | Methods and compositions for regulating biofilm development | |
JP2021169494A (en) | Colloidal antibacterial and antibiotic adhesion coatings used on the surface | |
CN106962498B (en) | Nisin/chitosan nanoparticle antibacterial film and preparation method and application thereof | |
He et al. | Electrospun PVA/gelatin based nanofiber membranes with synergistic antibacterial performance | |
Melo et al. | In vivo and in vitro antifungal effect of fungal chitosan nanocomposite edible coating against strawberry phytopathogenic fungi | |
Xiong et al. | Ultra-high strength sodium alginate/PVA/PHMB double-network hydrogels for marine antifouling | |
CN115999462A (en) | A pH-responsive Mat@CS-Pro nanocapsule antifouling agent and its preparation method and application | |
Fang et al. | Intrinsically antibacterial thin film composite membranes with supramolecularly assembled lysozyme nanofilm as selective layer for molecular separation | |
EP1170359B1 (en) | Biojelly-producing microorganism, coating containing said microorganism and anti-fouling method | |
CN114287634B (en) | Probiotic-embedded Arabic gum composite fiber/capsule as well as preparation method and application thereof | |
Tantala et al. | ANTIMICROBIAL ACTIVITY OF CHITOSAN AND CARBOXYMETHYL CHITOSAN FROM DIFFERENT TYPES AND SOURCES OF CHITOSAN. | |
Zhao et al. | Layer-by-layer-assembled biomimetic microstructure surface with multiple synergistic antifouling performance | |
Guo et al. | Enzyme and pH dual-responsive CAP@ CS@ PLGA microcapsules for controlled release antibacterial application | |
Sason et al. | Biological control of soft rot in potato by κ-carrageenan carriers encapsulated microbial predators | |
Li et al. | Antimicrobial efficacy and cell adhesion inhibition of in situ synthesized ZnO nanoparticles/polyvinyl alcohol nanofibrous membranes | |
Hao et al. | pH-responsive allicin-based coatings with antibacterial and antifouling effects in marine environments | |
CN113243381B (en) | Composite mildew-proof antibacterial agent and preparation method thereof | |
CN112293416B (en) | Environment-friendly non-release CS-b-PEG (polyethylene glycol) antibacterial micelle and preparation method thereof | |
Yan et al. | Self-renewal poly-Schiff base/gallium-based liquid metal composite coatings triggered via water for superior antimicrobial performance under water | |
Lin et al. | Preparation of vanillin nanoparticle/polyvinyl alcohol/chitosan film and its application in preservation of large yellow croaker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |